(7S,8R,9S)-9-(1,3-Benzodioxol-5-yl)-7,8-dimethyl-8,9-dihydronaphtho[1,2-d][1,3]dioxol-6(7H)-one;naphtho[1,2-d]-1,3-dioxol-6(7H)-one, 9-(1,3-benzodioxol-5-yl)-8,9-dihydro-7,8-dimethyl-, (7S,8R,9S)- 

Niaprazine;Nopron;Niaprazinum [INN-Latin];Niaprazina [INN-Spanish];EINECS 248-431-5;BRN 0844157;27367-90-4;N-(3-(4-(p-Fluorophenyl)-1-piperazinyl)-1-methylpropyl)nicotinamide;Nicotinamide, N-(3-(4-(p-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-;N-(3-(4-(4-Fluorophenyl)-1-piperazinyl)-1-methylpropyl)-3-pyridinecarboxamide;Niaprazina;Niaprazinum;Niaprazine (INN);Nopron (TN);Niaprazine [INN:DCF];UNII-R2H3YN6E3L;AC1L2H2D;C20H25FN4O;1709 CERM;34426-53-4 (tri-hydrochloride);LS-96431;D07333;N-(4-(4-(4-FLUOROPHENYL)PIPERAZIN-1-YL)BUTAN-2-YL)NICOTINAMIDE;N-[4-[4-(4-fluorophenyl)piperazin-1-yl]butan-2-yl]pyridine-3-carboxamide;3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)-;3-Pyridinecarboxamide, N-(3-(4-(4-fluorophenyl)-1-piperazinyl)-1-methylpropyl)- (9CI);N-(3-(4-(4-fluorophenyl)-1-piperazinyl)- 1-methylpropyl)-3-pyridinecarboxamide